Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1997 Jul;35(7):1904–1908. doi: 10.1128/jcm.35.7.1904-1908.1997

Emergence of rifampin-resistant Rhodococcus equi in an infected foal.

S Takai 1, K Takeda 1, Y Nakano 1, T Karasawa 1, J Furugoori 1, Y Sasaki 1, S Tsubaki 1, T Higuchi 1, T Anzai 1, R Wada 1, M Kamada 1
PMCID: PMC229871  PMID: 9196223

Abstract

To investigate the emergence of rifampin resistance in Rhodococcus equi strains isolated from foals and their environment in Japan, we compared the in vitro antimicrobial susceptibilities to rifampin of 640 isolates from 64 infected foals and 98 soil isolates from their horse-breeding farms. As a control, 39 human isolates from patients with and without AIDS were also tested for susceptibility to rifampin. All of the isolates showed rifampin sensitivity, except isolates from one infected foal and two patients with AIDS that showed rifampin resistance. To investigate the emergence of rifampin-resistant R. equi in the infected foal, which had received rifampin monotherapy for a month before euthanasia, 99 isolates of R. equi from the lesions and 20 isolates from the intestinal contents of the one foal with rifampin-resistant organisms were analyzed for rifampin susceptibilities, pathogenicities, and ribotypes. Of the 99 isolates from the lesions, all of which were virulent R. equi strains containing a virulence plasmid with a size of 85 or 90 kb, 90 (91%) isolates were rifampin resistant (MIC, > or = 12.5 microg/ml). On the other hand, of the 20 isolates from the intestinal contents, 11 (55%) isolates showed rifampin resistance (MIC, > or = 25 microg/ml), and 5 of them were avirulent R. equi strains. Among these 101 rifampin-resistant R. equi isolates with and without virulence plasmids characterized by ribotyping, 58 were type I, 20 were type II, 11 were type III, and 12 were type IV. These results demonstrated that at least eight different rifampin-resistant R. equi strains emerged concurrently and respectively from the different lesions and intestinal contents of the infected foal.

Full Text

The Full Text of this article is available as a PDF (296.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arora S. K., Arjunan P. Molecular structure and conformation of rifamycin S, a potent inhibitor of DNA-dependent RNA polymerase. J Antibiot (Tokyo) 1992 Mar;45(3):428–431. doi: 10.7164/antibiotics.45.428. [DOI] [PubMed] [Google Scholar]
  2. Clavé D., Archambaud M., Rouquet R. M., Massip P., Moatti N. Activité in vitro de vingt antibiotiques sur Rhodococcus equi. Pathol Biol (Paris) 1991 May;39(5):424–428. [PubMed] [Google Scholar]
  3. Drancourt M., Bonnet E., Gallais H., Peloux Y., Raoult D. Rhodococcus equi infection in patients with AIDS. J Infect. 1992 Mar;24(2):123–131. doi: 10.1016/0163-4453(92)92746-6. [DOI] [PubMed] [Google Scholar]
  4. Gradon J. D., Timpone J. G., Schnittman S. M. Emergence of unusual opportunistic pathogens in AIDS: a review. Clin Infect Dis. 1992 Jul;15(1):134–157. doi: 10.1093/clinids/15.1.134. [DOI] [PubMed] [Google Scholar]
  5. Harvey R. L., Sunstrum J. C. Rhodococcus equi infection in patients with and without human immunodeficiency virus infection. Rev Infect Dis. 1991 Jan-Feb;13(1):139–145. doi: 10.1093/clinids/13.1.139. [DOI] [PubMed] [Google Scholar]
  6. Hillidge C. J. Use of erythromycin-rifampin combination in treatment of Rhodococcus equi pneumonia. Vet Microbiol. 1987 Aug;14(3):337–342. doi: 10.1016/0378-1135(87)90121-0. [DOI] [PubMed] [Google Scholar]
  7. Kenney D. G., Robbins S. C., Prescott J. F., Kaushik A., Baird J. D. Development of reactive arthritis and resistance to erythromycin and rifampin in a foal during treatment for Rhodococcus equi pneumonia. Equine Vet J. 1994 May;26(3):246–248. doi: 10.1111/j.2042-3306.1994.tb04379.x. [DOI] [PubMed] [Google Scholar]
  8. Lasker B. A., Brown J. M., McNeil M. M. Identification and epidemiological typing of clinical and environmental isolates of the genus Rhodococcus with use of a digoxigenin-labeled rDNA gene probe. Clin Infect Dis. 1992 Aug;15(2):223–233. doi: 10.1093/clinids/15.2.223. [DOI] [PubMed] [Google Scholar]
  9. Maggi N., Pasqualucci C. R., Ballotta R., Sensi P. Rifampicin: a new orally active rifamycin. Chemotherapy. 1966;11(5):285–292. doi: 10.1159/000220462. [DOI] [PubMed] [Google Scholar]
  10. McNeil M. M., Brown J. M. Distribution and antimicrobial susceptibility of Rhodococcus equi from clinical specimens. Eur J Epidemiol. 1992 May;8(3):437–443. doi: 10.1007/BF00158580. [DOI] [PubMed] [Google Scholar]
  11. Nordmann P., Keller M., Espinasse F., Ronco E. Correlation between antibiotic resistance, phage-like particle presence, and virulence in Rhodococcus equi human isolates. J Clin Microbiol. 1994 Feb;32(2):377–383. doi: 10.1128/jcm.32.2.377-383.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Nordmann P., Rouveix E., Guenounou M., Nicolas M. H. Pulmonary abscess due to a rifampin and fluoroquinolone resistant Rhodococcus equi strain in a HIV infected patient. Eur J Clin Microbiol Infect Dis. 1992 Jun;11(6):557–558. doi: 10.1007/BF01960815. [DOI] [PubMed] [Google Scholar]
  13. Prescott J. F., Hoover D. J., Dohoo I. R. Pharmacokinetics of erythromycin in foals and in adult horses. J Vet Pharmacol Ther. 1983 Mar;6(1):67–73. doi: 10.1111/j.1365-2885.1983.tb00456.x. [DOI] [PubMed] [Google Scholar]
  14. Prescott J. F., Nicholson V. M. The effects of combinations of selected antibiotics on the growth of Corynebacterium equi. J Vet Pharmacol Ther. 1984 Mar;7(1):61–64. doi: 10.1111/j.1365-2885.1984.tb00880.x. [DOI] [PubMed] [Google Scholar]
  15. Prescott J. F. Rhodococcus equi: an animal and human pathogen. Clin Microbiol Rev. 1991 Jan;4(1):20–34. doi: 10.1128/cmr.4.1.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Prescott J. F., Sweeney C. R. Treatment of Corynebacterium equi pneumonia of foals: a review. J Am Vet Med Assoc. 1985 Oct 1;187(7):725–728. [PubMed] [Google Scholar]
  17. Samies J. H., Hathaway B. N., Echols R. M., Veazey J. M., Jr, Pilon V. A. Lung abscess due to Corynebacterium equi. Report of the first case in a patient with acquired immune deficiency syndrome. Am J Med. 1986 Apr;80(4):685–688. doi: 10.1016/0002-9343(86)90825-9. [DOI] [PubMed] [Google Scholar]
  18. Sweeney C. R., Sweeney R. W., Divers T. J. Rhodococcus equi pneumonia in 48 foals: response to antimicrobial therapy. Vet Microbiol. 1987 Aug;14(3):329–336. doi: 10.1016/0378-1135(87)90120-9. [DOI] [PubMed] [Google Scholar]
  19. Takahashi T., Tsuji M., Kikuchi N., Ishihara C., Osanai T., Kasai N., Yanagawa R., Hiramune T. Assignment of the bacterial agent of urinary calculus in young rats by the comparative sequence analysis of the 16S rRNA genes of corynebacteria. J Vet Med Sci. 1995 Jun;57(3):515–517. doi: 10.1292/jvms.57.515. [DOI] [PubMed] [Google Scholar]
  20. Takai S., Iie M., Kobayashi C., Morishita T., Nishio T., Ishida T., Fujimura T., Sasaki Y., Tsubaki S. Monoclonal antibody specific to virulence-associated 15- to 17-kilodalton antigens of Rhodococcus equi. J Clin Microbiol. 1993 Oct;31(10):2780–2782. doi: 10.1128/jcm.31.10.2780-2782.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Takai S., Ikeda T., Sasaki Y., Watanabe Y., Ozawa T., Tsubaki S., Sekizaki T. Identification of virulent Rhodococcus equi by amplification of gene coding for 15- to 17-kilodalton antigens. J Clin Microbiol. 1995 Jun;33(6):1624–1627. doi: 10.1128/jcm.33.6.1624-1627.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Takai S., Imai Y., Fukunaga N., Uchida Y., Kamisawa K., Sasaki Y., Tsubaki S., Sekizaki T. Identification of virulence-associated antigens and plasmids in Rhodococcus equi from patients with AIDS. J Infect Dis. 1995 Nov;172(5):1306–1311. doi: 10.1093/infdis/172.5.1306. [DOI] [PubMed] [Google Scholar]
  23. Takai S., Koike K., Ohbushi S., Izumi C., Tsubaki S. Identification of 15- to 17-kilodalton antigens associated with virulent Rhodococcus equi. J Clin Microbiol. 1991 Mar;29(3):439–443. doi: 10.1128/jcm.29.3.439-443.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Takai S., Ohbushi S., Koike K., Tsubaki S., Oishi H., Kamada M. Prevalence of virulent Rhodococcus equi in isolates from soil and feces of horses from horse-breeding farms with and without endemic infections. J Clin Microbiol. 1991 Dec;29(12):2887–2889. doi: 10.1128/jcm.29.12.2887-2889.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Takai S., Sasaki Y., Ikeda T., Uchida Y., Tsubaki S., Sekizaki T. Virulence of Rhodococcus equi isolates from patients with and without AIDS. J Clin Microbiol. 1994 Feb;32(2):457–460. doi: 10.1128/jcm.32.2.457-460.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Takai S., Sekizaki T., Ozawa T., Sugawara T., Watanabe Y., Tsubaki S. Association between a large plasmid and 15- to 17-kilodalton antigens in virulent Rhodococcus equi. Infect Immun. 1991 Nov;59(11):4056–4060. doi: 10.1128/iai.59.11.4056-4060.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Takai S., Watanabe Y., Ikeda T., Ozawa T., Matsukura S., Tamada Y., Tsubaki S., Sekizaki T. Virulence-associated plasmids in Rhodococcus equi. J Clin Microbiol. 1993 Jul;31(7):1726–1729. doi: 10.1128/jcm.31.7.1726-1729.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Tanaka Y., Yazawa K., Dabbs E. R., Nishikawa K., Komaki H., Mikami Y., Miyaji M., Morisaki N., Iwasaki S. Different rifampicin inactivation mechanisms in Nocardia and related taxa. Microbiol Immunol. 1996;40(1):1–4. doi: 10.1111/j.1348-0421.1996.tb03303.x. [DOI] [PubMed] [Google Scholar]
  29. Tkachuk-Saad O., Prescott J. Rhodococcus equi plasmids: isolation and partial characterization. J Clin Microbiol. 1991 Dec;29(12):2696–2700. doi: 10.1128/jcm.29.12.2696-2700.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Van Etta L. L., Filice G. A., Ferguson R. M., Gerding D. N. Corynebacterium equi: a review of 12 cases of human infection. Rev Infect Dis. 1983 Nov-Dec;5(6):1012–1018. doi: 10.1093/clinids/5.6.1012. [DOI] [PubMed] [Google Scholar]
  31. Woolcock J. B., Farmer A. M., Mutimer M. D. Selective medium for Corynebacterium equi isolation. J Clin Microbiol. 1979 May;9(5):640–642. doi: 10.1128/jcm.9.5.640-642.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES